Extrapulmonary neuroendocrine carcinoma (EP-NEC) is a rare and aggressive cancer that is often misunderstood and diagnosed late.

 

In this video for patients and care partners, Jessica Thomas, Director of Patient Education at the Neuroendocrine Tumour Research Foundation, highlights why specialist care is essential for people with EP-NEC. She introduces the concept of “thrivership” and explains how finding the right support can help with informed decision-making and values-aligned care.

 

Jessica emphasises the importance of expert treatment and connection with advocacy organisations, and explores the possibilities offered by evolving therapeutic options.

 

Clinical takeaways

 

  • EP-NEC is a distinct and aggressive subtype of neuroendocrine cancer, characterised by late diagnosis, frequent mis-categorisation, and mis-understanding 
  • Delays in diagnosis, inconsistent treatment pathways, limited specialist access, and patient confusion underscore the complexity and burden of EP-NEC 
  • Given the complexity of EP-NEC, patients require expert care from specialists knowledgeable in neuroendocrine carcinoma, as generic care is insufficient to address the aggressive nature and unique challenges of this disease 
  • Thrivership in the context of EP-NEC includes finding agency around the things that can be controlled, understanding the disease, the urgency of diagnosis and management, and evolving treatment options
  • To increase awareness and understanding of the complex nature and burden of disease associated with EP-NEC 
  • To share patient and HCP perspectives on obtaining a diagnosis of EP-NEC and subsequent treatment experiences 
  • To understand the potential future treatment options in EP-NEC 

Jessica Thomas, LCSW is a patient education leader and licensed clinical social worker with more than 20 years of experience walking alongside individuals and families living with cancer and chronic illness. She currently serves as Director of Patient Education at the Neuroendocrine Tumor Research Foundation (NETRF), where she helps turn the latest research and medical knowledge into clear, practical resources for people affected by neuroendocrine cancer. 

Jessica’s work focuses on meeting patients and caregivers where they are—acknowledging the uncertainty, fear, and questions that come with a diagnosis, while also helping people feel informed, supported, and empowered. She leads educational programs that include national conferences, virtual and in-person events, podcasts, patient guides, and digital tools, all designed to make complex information more understandable and usable in everyday life. 

Before joining NETRF, Jessica spent much of her career as a mental health clinician, supporting individuals coping with life-changing diagnoses, long-term treatment, and the emotional impact of serious illness. That clinical foundation continues to shape her approach to patient education, with an emphasis on resilience, communication, and quality of life—not just disease management. 

Jessica is deeply committed to amplifying patient and caregiver voices and believes that education is most powerful when it is compassionate, accessible, and grounded in real lived experience. 

Programme summary
  • clock Duration 4 MIN
  • clock Language(s) flag
Watch the video now
Other episodes of this series
Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC)

Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC)

Insights for patients and care partners 

Thriving beyond an EP-NEC diagnosis

Thriving beyond an EP-NEC diagnosis

Perspectives on treatment and care 

Current Episode
Share this programme
This educational programme is supported by an Independent Educational Grant from Boehringer Ingelheim 
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Boehringer Ingelheim 
Endorsement
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
NET CONNECT

NET CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Ipsen, Eisai Europe Limited, ITM and Boehringer Ingelheim

Meet the experts Independent IME approved

Other programmes of interest

patient-support Patient Support

Episode

1

of 2

episode
Oncology Endocrinology Rare diseases 
Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC)

Insights for patients and care partners 

Experts
Meredith Cummins
Endorsed by
INCA
NeuroEndocrine Cancer Australia Neuroendocrine Cancer Foundation NET-Research-Foundation
Neuroendocrine Cancer UK Minkhas mission
  • clock 5 MIN
  • calendar Dec 2025
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Boehringer Ingelheim 
eks
EKS / On-demand webinar
Oncology 
ESMO 2025: Gastric and gastroesophageal cancer insights for clinical practice

On-demand materials from an Experts Knowledge Share event

Experts
Dr Elizabeth Smyth, Prof. Aziz Zaanan, Prof. Markus Moehler
Endorsed by
ESDO
Digestive Cancers Europe
ICAN international cancer advocacy network
  • download Downloadable
    Resources
  • clock 67 MIN
  • calendar Dec 2025
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Amgen.
podcast Video podcast
Oncology Endocrinology Rare diseases 
Understanding EP-NEC: Through diagnosis, treatment, and support

A medical oncologist and a patient advocate share their perspectives

Experts
Dr Aman Chauhan, Susan Meckler-Plummer, RN
Endorsed by
Minkhas mission Neuroendocrine Cancer UK Neuroendocrine Cancer Foundation
NET-Research-Foundation
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Nov 2025
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Boehringer Ingelheim 
conference-update Conference update
Oncology 
Update from AACR–NCI–EORTC 2025: PYNNACLE Phase 2 evaluating rezatapopt in TP53 Y220C–mutant solid tumours

Clinical insights and expert discussion

Experts
Dr Alison Schram, Dr Elena Garralda
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar Oct 2025

This programme has been sponsored by PMV Pharma